Analysis of CMV-specific T-cell reconstitution following BMT to identify patients risk of late onset CMV disease

被引：0
|
作者：
Hebart, H
Krause, H
Wagner, I
Muller, CA
Jahn, G
Einsele, H
机构：
[1] MED KLIN & POLIKLIN,TUBINGEN,GERMANY
[2] INST KLIN & EPIDEMIOL VIRUSKRANKHEITEN,TUBINGEN,GERMANY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：852 / 852
页数：1
相关论文
共 50 条
  • [21] Monitoring of CMV-specific T-cell levels after organ transplantation
    Sester, Martina
    Gaertner, Barbara C.
    Sester, Urban
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2008, 32 (03): : 121 - 130
  • [22] Role of regulatory T cells in adoptive CMV-Specific T-Cell therapy
    Zwinger, Sandra
    Brestrich, Gordon
    Roemhild, Andy
    Maciejewski, Jaroslaw P.
    Kurtz, Andreas
    Reinke, Petra D.
    Volk, Hans D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 617 - 617
  • [23] Dissecting the Requirements for Maintenance of the CMV-Specific Memory T-Cell Pool
    Loewendorf, Andrea I.
    Arens, Ramon
    Purton, Jared F.
    Surh, Charles D.
    Benedict, Chris A.
    VIRAL IMMUNOLOGY, 2011, 24 (04) : 351 - 355
  • [24] The hallmarks of CMV-specific CD8 T-cell differentiation
    van den Berg, Sara P. H.
    Pardieck, Iris N.
    Lanfermeijer, Josien
    Sauce, Delphine
    Klenerman, Paul
    van Baarle, Debbie
    Arens, Ramon
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2019, 208 (3-4) : 365 - 373
  • [25] The potential association of CMV-specific CD8+T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients
    EL-Din, Ahmed Ali Shams
    El-Desoukey, Nermeen Ahmed
    Tawadrous, Dalia Gamil Amin
    Fouad, Neveen Mohammed Baha EL-Din
    Abdel-Mooti, Mohammed
    Hotar, Said Fathy
    HEMATOLOGY, 2018, 23 (08) : 463 - 469
  • [26] Characterization of CMV-specific CD4*T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation
    Raeiszadeh, Mohammad
    Pachnio, Annette
    Begum, Jusnara
    Craddock, Charles
    Moss, Paul
    Chen, Frederick E.
    HAEMATOLOGICA, 2015, 100 (08) : E318 - E322
  • [27] Large-scale GMP-grade production of CMV-specific T-cell lines using CMV-specific peptides for clinical use
    D'Amico, G.
    Dander, E.
    Perseghin, P.
    Gaipa, G.
    Beotti, D.
    Balduzzi, A.
    Rovelli, A.
    Pira, G. Li
    Manca, F.
    Introna, M.
    Rambaldi, A.
    Biondi, A.
    Biagi, E.
    CYTOTHERAPY, 2006, 8
  • [28] EARLY CMV-SPECIFIC T CELL RESPONSE AND EGFR IDENTIFY PATIENTS AT HIGH RISK OF INFECTION AFTER RENAL TRANSPLANTATION
    Leone, Francesca
    Mauro, Maria Vittoria
    Gigliotti, Paolo
    Lofaro, Danilo
    Perri, Anna
    Vizza, Donatella
    Lupinacci, Simona
    Toteda, Giuseppina
    La Russa, Antonella
    Mollica, Agata
    Papalia, Teresa
    Giraldi, Cristina
    Bonofiglio, Renzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [29] PROSPECTIVE RANDOMIZED TRIAL FOR PREDICTING CMV INFECTION ACCORDING TO BASELINE CMV-SPECIFIC T-CELL IMMUNITY IN KIDNEY TRANSPLANT PATIENTS
    Jarque, Marta
    Melilli, Edoardo
    Gutierrez, Alex
    Moreso, Francesc
    Guirado, Llu Is
    Manonelles, Anna
    Cruzado, Josep M.
    Luque, Sergi
    Crespo, Elena
    Arana, Pilar
    Montero, Nuria
    Diekman, Fritz
    TRANSPLANT INTERNATIONAL, 2017, 30 : 87 - 87
  • [30] Analysis of CMV specific T-cell reconstitution after allogeneic BMT form HLA-identical sibling or unrelated donors
    Krause, H
    Einsele, H
    Wagner, I
    Hebart, H
    Muller, C
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P748 - P748
12345